Health Economic Evaluation of costs and benefits of a computer based program called "Deprexis" used for insured persons of the DAK (statutory health insurance) suffering from depression

Health Economic Evaluation of costs and benefits of a computer based program called "Deprexis" used for insured persons of the DAK (statutory health insurance) suffering from depression - Study "Deprexis"

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00003564

Enrollment

5400

Registered

2012-02-17

Start date

2012-02-17

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F32.0 F32.1

Interventions

Group 1: The intervention group uses the program Deprexis for a period of 12 weeks. The Questionnaires applied measure: Depression: PHQ-9, quality of life: SF12 and EQ-5D, Questionnaire working and ad

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: (a) At least a mild depression: PHQ-9 >= 5 (b) age of at least 18 years (c) Informed Consent (d) Insured by the DAK at least for one year and availabilty of costs one year before and one year after the treatment with "Deprexis" (e) Access to the internet

Exclusion criteria

Exclusion criteria: Danger of suizidal tendencies; measured by item number 9 of the questionnaire PHQ-9 (value > 0)

Design outcomes

Primary

Measure	Time frame
costs, that occured in a period of one year after the end of treatment determined by the DAK (Statutory Health Insurance)	—

Secondary

Measure	Time frame
Quality of life measured by the SF12 and the EQ-5D at the beginning (T0), after 12 weeks (T1), after 6 months (T2) and after 12 months (T3). The severity of depression: by the PHQ-9 at the beginning (T0), after 12 weeks (T1), after 6 months (T2) and after 12 months (T3). The social functioning: measured by the WSAS at the beginning (T0), after 12 weeks (T1), after 6 months (T2) and after 12 months (T3).	—

Measure

Time frame

Quality of life measured by the SF12 and the EQ-5D at the beginning (T0), after 12 weeks (T1), after 6 months (T2) and after 12 months (T3). The severity of depression: by the PHQ-9 at the beginning (T0), after 12 weeks (T1), after 6 months (T2) and after 12 months (T3). The social functioning: measured by the WSAS at the beginning (T0), after 12 weeks (T1), after 6 months (T2) and after 12 months (T3).

—

Countries

Germany

Contacts

Public ContactWolfgang Greiner

Fakultät für Gesundheitswissenschaften Arbeitsgruppe 5: Gesundheitsökonomie und Gesundheitsmanagement

dak-gesundheit@deprexis.de+49.521.1066989

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026